Cargando…
Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016961/ https://www.ncbi.nlm.nih.gov/pubmed/33795635 http://dx.doi.org/10.1038/s41392-021-00557-9 |
| _version_ | 1783673964869976064 |
|---|---|
| author | Zhang, Chenyue Wang, Haiyong |
| author_facet | Zhang, Chenyue Wang, Haiyong |
| author_sort | Zhang, Chenyue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8016961 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80169612021-04-16 Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials Zhang, Chenyue Wang, Haiyong Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2021-04-01 /pmc/articles/PMC8016961/ /pubmed/33795635 http://dx.doi.org/10.1038/s41392-021-00557-9 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Research Highlight Zhang, Chenyue Wang, Haiyong Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials |
| title | Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials |
| title_full | Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials |
| title_fullStr | Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials |
| title_full_unstemmed | Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials |
| title_short | Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials |
| title_sort | therapeutic utility of lung-map: ushering into an era of genomic and biomarker-driven clinical trials |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016961/ https://www.ncbi.nlm.nih.gov/pubmed/33795635 http://dx.doi.org/10.1038/s41392-021-00557-9 |
| work_keys_str_mv | AT zhangchenyue therapeuticutilityoflungmapusheringintoaneraofgenomicandbiomarkerdrivenclinicaltrials AT wanghaiyong therapeuticutilityoflungmapusheringintoaneraofgenomicandbiomarkerdrivenclinicaltrials |